Chesapeake Corp

Chesapeake — Debt Investor Presentation (August 2006)

41 slides from Chesapeake's debt investor presentation, Aug 10, 2006

  1. Slide 1: Chesapeake Corp. Lender Presentation

    Exhibit 99.1 Chesapeake Corp. Lender Presentation 1 August 9, 2006

  2. Slide 2: Disclaimer

    Disclaimer This presentation includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Changes in the following important factors, among others, could cause Chesapeake’s actual results to differ materially from t

  3. Slide 3: Agenda

    Agenda Wachovia Securities Welcome Address Andrew Kohut Company Overview CEO & President Market Overview Joel Mostrom Historical Financial Summary Senior Vice President & CFO Cash Flow & Profitability Initiatives Management Team Conclusion / Q&A Wachovia Securities Credit Facilities Candace Formacek

  4. Slide 4: Company Overview

    ot ia ~~ Company Overview

  5. Slide 5: Business Summary

    Business Summary • A leading supplier of value-added, specialty paperboard packaging in Europe • A leading supplier of specialty plastic packaging products to niche end- use markets • Focus on higher growth, lower cyclicality end-use markets that require rigorous process & quality control, brand pos

  6. Slide 6: A Leading Producer of Value-Added, Specialty Packaging Products

    A Leading Producer of Value-Added, Specialty Packaging Products Paperboard Packaging Plastic Packaging Revenue Contribution: 83% of FY 2005 Revenue 17% of FY 2005 Revenue Products & Services: Folding cartons, booklets, leaflets, HDPE bottles, closures and labels, composite tubes, rigid set-up contai

  7. Slide 7: A Leading W. European Paper-based Specialty Packaging Company

    A Leading W. European Paper-based Specialty Packaging Company Folding CartonsLabels and Leaflets Mayr Melnhof Chesapeake MeadWestvaco MY Holdings VGB A&R Amcor Edelmann Reno de Medici Graphic Packaging 0 100 200 300 400 500 600 700 800 900 Sales - $ in millions Note: Based on estimated 2004 sales va

  8. Slide 8: Broad Specialty Packaging Portfolio

    Broad Specialty Packaging Portfolio 8

  9. Slide 9: Innovative, Design Focused Packaging Solutions

    Innovative, Design Focused Packaging Solutions Our award winning design teams work with customers to develop innovative solutions for technically demanding or brand focused packaging applications • Created a striking six-color • Partnered with GlaxoSmithKline in • Produced a “Fairy Tale” vodka pack

  10. Slide 10: Diversified Across Markets & Geographies

    Diversified Across Markets & Geographies 2005 Sales by Market 2005 Sales by Geography South Africa Other Plastics Pharma- Belgium 4% 4% 17% Healthcare 36% 6% Ireland 8% Germany Tobacco 12% 13% United States 3% France 11% 34% United Kingdom Branded Products 52% (Alcoholic Drinks, Confectioneries & Co

  11. Slide 11: Long-Standing Relationships with Blue Chip Customers

    Long-Standing Relationships with Blue Chip Customers 11

  12. Slide 12: Why We Are Successful

    Why We Are Successful Comprehensive Design Expertise Significant investment in design capabilities Collaborative design relationship with customers + Broad Network of State-of-the-Art Facilities & Long-term Customer Relationships 48 sector-focused, efficient manufacturing facilities Strategically lo

  13. Slide 13: Market Overview

    4 (4 -— Market Overview

  14. Slide 14: Pharmaceuticals & Healthcare Market

    Pharmaceuticals & 36% Healthcare Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increasing use of lifestyle drugs • Comprehensive design services • Aging population • Special packaging features • Increasing OTC drug sales •

  15. Slide 15: Branded Products Market

    Branded Products 34% Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increased consumer marketing • Brand positioning/differentiation in focus on promotional discerning global markets packaging • Multi-substrate capabilities

  16. Slide 16: Tobacco Market

    13% Tobacco Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Good growth projected in • Supplier rationalization developing countries • Shift from soft to hard pack • Low/negative growth in • Advertising restrictions lead to

  17. Slide 17: Plastics Market

    17% Plastics Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increased soft drink and • Lighter weight containers for mineral water consumption agrochemicals and other specialty • Barrier containers for chemicals with superi

  18. Slide 18: #1 Focus is to Increase Cash Flow & Profitability

    #1 Focus is to Increase Cash Flow & Profitability Cost Savings Program - $25 million Cost of Capital - Refinancing resulting in $3 million plus in annual interest savings Proactive Management of Legacy Pension Obligations Increased Organic Growth - Worldwide Cash Flow pharmaceutical packaging demand

  19. Slide 19: Historical Financial Summary

    Historical Financial Summary 19

  20. Slide 20: Key Financial Highlights

    Key Financial Highlights • CSK financial performance from 2002 -2004 – Reported revenue, gross profit and Adjusted EBITDA increased annually – Cash flow from operations increased at a 35% CAGR – Debt was reduced by $62.5 million • Financial performance has declined in 2005 and YTD 2006 – The decline

  21. Slide 21: Reported Historical Financial Summary

    Reported Historical Financial Summary Historical Financial Summary ($ in millions) Fiscal Year End LTM 2002 2003 2004 2005 7/2/2006 Total Net Sales $781.8 $885.6 $1,031.7 $1,042.0 $1,012.7 % Growth n/a 13.3% 16.5% 1.0% n/a Total Gross Profit 141.8 163.4 173.3 176.5 169.8 % Margin 18.1% 18.5% 16.8% 1

  22. Slide 22: Paperboard Business Segment

    Paperboard Business Segment Revenue Adjusted EBITDA $120 $1,000 $104.0 $864.7 $860.2 $99.0 $846.5 $96.6 $90.5 $753.4 $90 $750 $500 $60 $250 $30 $0 $0 FY '03 FY '04 FY '05 LTM 7/2/06 FY '03 FY '04 FY '05 LTM 7/2/06 Based on 2003 exchange rates FX Impact Based on 2003 exchange rates FX Impact • Adjust

  23. Slide 23: Plastics Business Segment

    Plastics Business Segment Revenue Adjusted EBITDA $200 $32 $181.8 $167.0 $166.2 $26.0 $24.6 $24.3 $150 $22.6 $132.2 $24 $100 $16 $50 $8 $0 $0 FY '03 FY '04 FY '05 LTM 7/2/06 FY '03 FY '04 FY '05 LTM 7/2/06 Based on 2003 exchange rates FX Impact Based on 2003 exchange rates FX Impact • Adjusted EBITD

  24. Slide 24: Normalized Performance

    Normalized Performance Normalized Performance ($ in millions) Fiscal Years Ended LTM 2003 2004 2005 7/2/2006 Adjusted EBITDA $110.7 $108.9 $104.4 $98.9 (1) Foreign exchange impact - (12.8) (12.2) (9.0) (1) Pension increase over 2003 - 4.2 9.2 12.8 (1) French luxury packaging (income) loss (0.5) 2.4

  25. Slide 25: Proactive Management of Legacy Pension Obligations

    Proactive Management of Legacy Pension Obligations • Proactive management of legacy obligations • US Plan benefits frozen 12/05, UK Plan frozen to new entrants 12/05 • Reduced UK benefits level for new entrants in 2004 • Increased UK employer and employee contribution rates in 2004 • Rising discount

  26. Slide 26: Cash Flow & Profitability Initiatives

    Cash Flow & Profitability Initiatives 26

  27. Slide 27: Cost Savings Initiative

    Cost Savings Initiative • Publicly announced $25 million annual cost savings initiative – Two year implementation period: 2006 - 2007 – Estimated cost of $30 - $40 million pre-tax • Sale or closure of underperforming / underutilized assets • General workforce reduction • Process improvement and over

  28. Slide 28: Cost Savings Initiative: Progress to Date

    Cost Savings Initiative: Progress to Date • Completed the closure of the Birmingham facility (food and household) in April 2006 – Severance benefits have been paid to approximately 190 employees • Sold the Lurgan facility (food and beverage) in March 2006 – Facility not viewed as a strategic fit • I

  29. Slide 29: Cost Savings Initiative: On-going and Future Initiatives

    Cost Savings Initiative: On-going and Future Initiatives • On-going and future initiatives include: – Additional Facility Rationalizations – Additional Workforce Reduction – Additional Process Improvement Initiatives • The global $25 million initiative represents identifiable costs that have been, o

  30. Slide 30: #1 Focus is to Increase Cash Flow & Profitability

    #1 Focus is to Increase Cash Flow & Profitability Cost Savings Program - $25 million Cost of Capital - Refinancing resulting in $3 million plus in annual interest savings Proactive Management of Legacy Pension Obligations Increased Organic Growth - Worldwide Cash Flow pharmaceutical packaging demand

  31. Slide 31: Comparison of Debt Breakdown

    Comparison of Debt Breakdown Debt Currency Mix Fixed vs. Variable Debt 100% 100% Variable, 7% USD, 12% Variable, 32% USD, 35% 75% 75% Euro, 29% 50% Euro, 29% 50% Fixed, 93% Fixed, 68% Sterling, 59% 25% 25% Sterling, 36% 0% 0% Reported 7/2/06 Proforma for transaction Reported 7/2/06 Proforma for tran

  32. Slide 32: Debt Maturity Schedule

    Debt Maturity Schedule $200 Pro Forma for Transaction 150 100 $123 $122 $128 50 $50 $22 $5 $5 $3 $5 $3 0 2006 2007 2008 2009 2010 2011 2012 2013 2014 2019 Senior Debt Subordinated Debt 32

  33. Slide 33: Conclusion / Q&A

    4 - ~~ Conclusion / Q&A

  34. Slide 34: Conclusion / Q&A

    Conclusion / Q&A • Market leadership position in targeted markets • Comprehensive design and manufacturing capabilities • Global manufacturing presence – strategically located • Long-term customer relationships (top ten average > 30 years) • Designated as “Primary Supplier” to many of its customers

  35. Slide 35: Credit Facilities

    4 (4 -t Credit Facilities

  36. Slide 36: Sources & Uses

    Sources & Uses • Current: Refinance the existing credit facilities and pay fees and expenses associated with the Credit Facilities • November 15th: Fund the Delayed Draw Term Loan with proceeds utilized to call the Notes and pay the associated call premium of 105.1875% Sources Uses ($ in millions) R

  37. Slide 37: Pro Forma Capitalization

    Pro Forma Capitalization • Holding debt constant, leverage is reduced to 3.8x utilizing the $25 million savings targeted Pro Forma Capitalization ($ in millions) Pro Forma At Close 7/2/06 Cumulative Pro Forma Post Redemption Cumulative Cumulative (4) (5) Book Capitalization Multiple of Book Capitali

  38. Slide 38: Summary Terms

    Summary Terms BORROWER: Chesapeake Corporation and various foreign subsidiary borrowers SOLE BOOKRUNNER: Wachovia Capital Markets, LLC CO-LEAD ARRANGERS: Wachovia Capital Markets, LLC and Banc of America Securities LLC FACILITIES: $125 million 5-Year Revolving Credit Facility £70 million 7-Year Term

  39. Slide 39: Appendix

    of ia ~“ Appendix

  40. Slide 40: Financial Reconciliations

    Financial Reconciliations Reconciliation of Adjusted EBITDA and Adjusted EBIT to EBIT ($ in millions) Year-Ended LTM December 29, December 28, January 2, January 1, July 2, 2002 2003 2005 2006 2006 Sales from continuing operations: Paperboard Packaging $678.1 $753.4 $864.7 $860.2 $846.5 Plastic Pack

  41. Slide 41: Chesapeake Corp. Lender Presentation

    Chesapeake Corp. Lender Presentation 41 August 9, 2006

Chesapeake — Debt Investor Presentation (August 2006) on 6ix